{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:12:18Z","timestamp":1792843938474,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7412","license":[{"start":{"date-parts":[[2012,7,8]],"date-time":"2012-07-08T00:00:00Z","timestamp":1341705600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,7,8]],"date-time":"2012-07-08T00:00:00Z","timestamp":1341705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1038\/nature11307","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T06:52:45Z","timestamp":1341557565000},"page":"508-511","source":"Crossref","is-referenced-by-count":358,"title":["TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis"],"prefix":"10.1038","volume":"488","author":[{"given":"Adam P.","family":"Gregory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calliope A.","family":"Dendrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine E.","family":"Attfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiden","family":"Haghikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysia K.","family":"Xifara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Butter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gereon","family":"Poschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurman","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A.","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Pr\u00f6mel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Punwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Felce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn C.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John I.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"McVean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Fugger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,8]]},"reference":[{"key":"BFnature11307_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature09792","volume":"470","author":"ES Lander","year":"2011","unstructured":"Lander, E. S. Initial impact of the sequencing of the human genome. Nature 470, 187\u2013197 (2011)","journal-title":"Nature"},{"key":"BFnature11307_CR2","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1056\/NEJMp0806284","volume":"360","author":"DB Goldstein","year":"2009","unstructured":"Goldstein, D. B. Common genetic variation and human traits. N. Engl. J. Med. 360, 1696\u20131698 (2009)","journal-title":"N. Engl. J. Med."},{"key":"BFnature11307_CR3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/ng.401","volume":"41","author":"PL De Jager","year":"2009","unstructured":"De Jager, P. L. et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature Genet. 41, 776\u2013782 (2009)","journal-title":"Nature Genet."},{"key":"BFnature11307_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214\u2013219 (2011)","journal-title":"Nature"},{"key":"BFnature11307_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/ng.582","volume":"42","author":"EA Stahl","year":"2010","unstructured":"Stahl, E. A. et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nature Genet. 42, 508\u2013514 (2010)","journal-title":"Nature Genet."},{"key":"BFnature11307_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ng.694","volume":"42","author":"A Strange","year":"2010","unstructured":"Strange, A. et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nature Genet. 42, 985\u2013990 (2010)","journal-title":"Nature Genet."},{"key":"BFnature11307_CR7","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ng.717","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke, A. et al. Genome-wide meta-analysis increases to 71 the number of confirmed \u2019Crohn\u2019s disease susceptibility loci. Nature Genet. 42, 1118\u20131125 (2010)","journal-title":"Nature Genet."},{"key":"BFnature11307_CR8","doi-asserted-by":"crossref","unstructured":"The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061\u20131073 (2010)","DOI":"10.1038\/nature09534"},{"key":"BFnature11307_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrneurol.2011.1","volume":"7","author":"X Bosch","year":"2011","unstructured":"Bosch, X., Saiz, A. & Ramos-Casals, M. Monoclonal antibody therapy-associated neurological disorders. Nature Rev. Neurol. 7, 165\u2013172 (2011)","journal-title":"Nature Rev. Neurol."},{"key":"BFnature11307_CR10","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","volume":"47","author":"BW van Oosten","year":"1996","unstructured":"van Oosten, B. W. et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47, 1531\u20131534 (1996)","journal-title":"Neurology"},{"key":"BFnature11307_CR11","doi-asserted-by":"crossref","unstructured":"The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS\/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53, 457\u2013465 (1999)","DOI":"10.1212\/WNL.53.3.457"},{"key":"BFnature11307_CR12","doi-asserted-by":"publisher","first-page":"e1000529","DOI":"10.1371\/journal.pgen.1000529","volume":"5","author":"BN Howie","year":"2009","unstructured":"Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009)","journal-title":"PLoS Genet."},{"key":"BFnature11307_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrm2777","volume":"10","author":"M Chen","year":"2009","unstructured":"Chen, M. & Manley, J. L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nature Rev. Mol. Cell Biol. 10, 741\u2013754 (2009)","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnature11307_CR14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrm2430","volume":"9","author":"S Sch\u00fctze","year":"2008","unstructured":"Sch\u00fctze, S., Tchikov, V. & Schneider-Brachert, W. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nature Rev. Mol. Cell Biol. 9, 655\u2013662 (2008)","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnature11307_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/ar2197","volume":"9","author":"FC Kimberley","year":"2007","unstructured":"Kimberley, F. C., Lobito, A. A., Siegel, R. M. & Screaton, G. R. Falling into TRAPS \u2013 receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res. Ther. 9, 217 (2007)","journal-title":"Arthritis Res. Ther."},{"key":"BFnature11307_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1084\/jem.170.2.607","volume":"170","author":"FM Hofman","year":"1989","unstructured":"Hofman, F. M., Hinton, D. R., Johnson, K. & Merrill, J. E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170, 607\u2013612 (1989)","journal-title":"J. Exp. Med."},{"key":"BFnature11307_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1056\/NEJM199108153250704","volume":"325","author":"MK Sharief","year":"1991","unstructured":"Sharief, M. K. & Hentges, R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325, 467\u2013472 (1991)","journal-title":"N. Engl. J. Med."},{"key":"BFnature11307_CR18","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/brain\/123.10.2005","volume":"123","author":"L Probert","year":"2000","unstructured":"Probert, L. et al. TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 123, 2005\u20132019 (2000)","journal-title":"Brain"},{"key":"BFnature11307_CR19","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/eji.1830240916","volume":"24","author":"D Baker","year":"1994","unstructured":"Baker, D. et al. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24, 2040\u20132048 (1994)","journal-title":"Eur. J. Immunol."},{"key":"BFnature11307_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nm0198-078","volume":"4","author":"J Liu","year":"1998","unstructured":"Liu, J. et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nature Med. 4, 78\u201383 (1998)","journal-title":"Nature Med."},{"key":"BFnature11307_CR21","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1093\/brain\/awr203","volume":"134","author":"E Taoufik","year":"2011","unstructured":"Taoufik, E. et al. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-\u03baB. Brain 134, 2722\u20132735 (2011)","journal-title":"Brain"},{"key":"BFnature11307_CR22","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1093\/brain\/awr199","volume":"134","author":"R Brambilla","year":"2011","unstructured":"Brambilla, R. et al. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain 134, 2736\u20132754 (2011)","journal-title":"Brain"},{"key":"BFnature11307_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature03727","volume":"435","author":"M Feldmann","year":"2005","unstructured":"Feldmann, M. & Steinman, L. Design of effective immunotherapy for human autoimmunity. Nature 435, 612\u2013619 (2005)","journal-title":"Nature"},{"key":"BFnature11307_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/ng.873","volume":"43","author":"DM Evans","year":"2011","unstructured":"Evans, D. M. et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genet. 43, 761\u2013767 (2011)","journal-title":"Nature Genet."},{"key":"BFnature11307_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/ng.789","volume":"43","author":"GF Mells","year":"2011","unstructured":"Mells, G. F. et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nature Genet. 43, 329\u2013332 (2011)","journal-title":"Nature Genet."},{"key":"BFnature11307_CR26","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston, A. & Coles, A. Multiple sclerosis. Lancet 372, 1502\u20131517 (2008)","journal-title":"Lancet"},{"key":"BFnature11307_CR27","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.1156409","volume":"322","author":"D Altshuler","year":"2008","unstructured":"Altshuler, D., Daly, M. J. & Lander, E. S. Genetic mapping in human disease. Science 322, 881\u2013888 (2008)","journal-title":"Science"},{"key":"BFnature11307_CR28","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/ng2088","volume":"39","author":"J Marchini","year":"2007","unstructured":"Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nature Genet. 39, 906\u2013913 (2007)","journal-title":"Nature Genet."},{"key":"BFnature11307_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3","volume":"44","author":"FK Chan","year":"2001","unstructured":"Chan, F. K. et al. Fluorescence resonance energy transfer analysis of cell surface receptor interactions and signaling using spectral variants of the green fluorescent protein. Cytometry 44, 361\u2013368 (2001)","journal-title":"Cytometry"},{"key":"BFnature11307_CR30","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nmeth978","volume":"3","author":"JR James","year":"2006","unstructured":"James, J. R., Oliveira, M. I., Carmo, A. M., Iaboni, A. & Davis, S. J. A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer. Nature Methods 3, 1001\u20131006 (2006)","journal-title":"Nature Methods"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature11307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature11307","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature11307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:02:40Z","timestamp":1684418560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature11307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,8]]},"references-count":30,"journal-issue":{"issue":"7412","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["BFnature11307"],"URL":"https:\/\/doi.org\/10.1038\/nature11307","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717952702.793458170","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,8]]}}}